Sunshine Biopharma Inc. (SBFM) › Operating IncomeSunshine Biopharma Inc. (SBFM) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$556.2K2012: -$706.7K2013: -$1.94M2014: -$1.76M2015: -$780.3K2016: -$993.1K2017: -$857.2K2018: -$1.16M2019: -$641.6K2020: -$576.9K2021: -$2.44M2022: -$27.00M2023: -$4.79M2024: -$5.81M2025: -$6.23M-$6.23M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$6.23M-7.1%2024-$5.81M-21.5%2023-$4.79M+82.3%2022-$27.00M-1006.5%2021-$2.44M-323.0%2020-$576.9K+10.1%2019-$641.6K+44.9%2018-$1.16M-35.8%2017-$857.2K+13.7%2016-$993.1K-27.3%2015-$780.3K+55.5%2014-$1.76M+9.3%2013-$1.94M-174.0%2012-$706.7K-27.1%2011-$556.2K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share